Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

795
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
795
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

418
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
418
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
Drug Regulation01:25

Drug Regulation

1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating Large Language Models into Thematic Analysis Workflows for Healthcare Research.

Studies in health technology and informatics·2026
Same author

Phase 2 study of the lysine-specific demethylase 1 inhibitor bomedemstat for essential thrombocythemia.

Blood advances·2026
Same author

African digital health strategic plans analysis: key weaknesses in contextualization, intervention focus, and technological foresight.

NPJ digital medicine·2025
Same author

Leveraging open-source large language models (LLMs) in scoping reviews: a case study on disability and AI applications.

International journal of medical informatics·2025
Same author

Advancing hierarchical neural networks with scale-aware pyramidal feature learning for medical image dense prediction.

Computer methods and programs in biomedicine·2025
Same author

Identifying key characteristics of developed artificial intelligence algorithms to achieve meaningful impact on Canadian healthcare: a scoping review protocol.

BMJ open·2025
Same journal

A GenAI Pipeline for Violinist Kinematic Data Management.

Studies in health technology and informatics·2026
Same journal

AMAL-For-Qatar: A Comprehensive AI Ecosystem for Fetal Ultrasound Analysis - Project Overview and Achievements.

Studies in health technology and informatics·2026
Same journal

Longitudinal Treatment-Aware Multimodal AI for Dermatology: A Scoping Review.

Studies in health technology and informatics·2026
Same journal

Predicting Postpartum Depression Using Imbalance-Aware Machine Learning.

Studies in health technology and informatics·2026
Same journal

Validation of Deep-Learning Models for Autosegmentation of Brain Metastases.

Studies in health technology and informatics·2026
Same journal

Delay-Dependent Gating in Modular RNNs.

Studies in health technology and informatics·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K

Enhancing Drug-Related Data Exchange: Advanced Technical Support for Interoperability.

James Liang1, Jean Noel Nikiema1

  • 1Centre de recherche en santé publique, Université de Montréal et CIUSSS du Centre-Sud-de-l'Île-de-Montréal, Montréal, Canada.

Studies in Health Technology and Informatics
|August 23, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces technical services to improve access to the Canadian Drug Ontology (OCRx). These tools enhance drug data retrieval and support the FAIR principles for broader research application.

Keywords:
FAIR ontologiesOntologieslook-up service

More Related Videos

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

4.4K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K

Related Experiment Videos

Last Updated: Jun 15, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K
TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

4.4K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K

Area of Science:

  • Biomedical Informatics
  • Pharmacology
  • Data Science

Background:

  • The Canadian Drug Ontology (OCRx) is a valuable resource for drug information.
  • Facilitating access and usability of complex ontologies like OCRx is crucial for research.
  • Existing methods for querying and accessing OCRx may present barriers to widespread adoption.

Purpose of the Study:

  • To develop and describe a suite of technical services for the Canadian Drug Ontology (OCRx).
  • To enhance the accessibility and interoperability of OCRx data for researchers.
  • To promote the application of Findable, Accessible, Interoperable, and Reusable (FAIR) principles to OCRx.

Main Methods:

  • Development of a lookup service (PaperRx) for retrieving OCRx drug entities via Description Logic queries (DLqueries).
  • Implementation of a SPARQL endpoint for semantic querying of OCRx.
  • Provision of an OWL file downloader and a RESTful Application Programming Interface (API) for programmatic access.

Main Results:

  • A comprehensive set of technical services has been successfully developed and deployed for OCRx.
  • The PaperRx service enables efficient retrieval of drug entities based on their classified structure.
  • The integrated services facilitate compliance with FAIR data principles for the OCRx ontology.

Conclusions:

  • The developed technical services significantly improve the usability and accessibility of the Canadian Drug Ontology (OCRx).
  • These services empower researchers to leverage OCRx data more effectively, adhering to FAIR data standards.
  • The enhanced accessibility of OCRx is expected to foster greater integration into drug discovery and pharmacovigilance research.